Literature DB >> 6719962

[Fe and Cu content in bones, muscles and whole body of growing rats with different Fe and Cu supplies].

M Kirchgessner, E Grassmann, J J Kim.   

Abstract

The Fe and Cu contents in the femur and in the skeleton muscle were investigated in a trial series with factorial Fe and Cu supplies of growing rats (0, 25, 250, and 625 micrograms of Fe supply; 0, 10, 100, and 250 micrograms Cu supply per g of the diet). In addition, the reaction of the carcass to the different trace element supply was compared to the changes of the Fe and Cu contents in organs and tissues. In the femur, the Fe contents clearly increase in all grades of the Cu supply with increasing Fe supply. But because of the reduced live weight of the trial animals without Fe supply, this is valid only from 25 micrograms Fe/g diet on. For all Fe levels, the influence of the Cu supply on the concentration and the content of Cu results in a plateau in the range of 10-100 micrograms Cu/g diet; it is not reached with Cu deficiency and exceeded with an excessive Cu supply (250 micrograms/g). A clear increase of the Fe concentration in the muscle occurs only at a supply of 250 micrograms Fe/g diet. A further increase at 625 micrograms Fe/g only occurs at a Cu supply of 250 micrograms/g. Generally, the Fe concentration is reduced in the Cu deficiency. The Cu concentration in the muscle increases in all cases with the Cu supply, and the extent of this increase is strongly influenced by the Fe supply. The Fe contents in the carcass primarily depend on the Fe dosage. For the total contents of copper there are hints of a homeostatical regulation in the range of 10-100 micrograms Cu/g, but it seems to be disturbed if the Fe supply (0 or 25 micrograms/g) is insufficient. The comparison of the Fe and Cu contents in organs and tissues to those in the carcass shows that the reactions to the different supply levels, which are clearly different in the tissues, can be reproduced but insufficiently by the trace element analysis in the carcass.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6719962     DOI: 10.1007/bf02020893

Source DB:  PubMed          Journal:  Z Ernahrungswiss        ISSN: 0044-264X


  11 in total

1.  Effects of different levels of dietary iron on pregnancy superimposed upon growth in the rat.

Authors:  W Lin; A Kirksey
Journal:  J Nutr       Date:  1976-04       Impact factor: 4.798

2.  [Utilization of suboptimal supplements of various iron compounds by the rat].

Authors:  E Grassmann
Journal:  Zentralbl Veterinarmed A       Date:  1977-12

3.  The ferrous to ferric cycles in iron metabolism.

Authors:  E Frieden
Journal:  Nutr Rev       Date:  1973-02       Impact factor: 7.110

4.  Relationships between copper, zinc and iron in the plasma, soft tissues and skeleton of the rat during Cu deficiency.

Authors:  B Alfaro; F W Heaton
Journal:  Br J Nutr       Date:  1973-01       Impact factor: 3.718

5.  [The utilization of iron through variable copper supply].

Authors:  E Grassmann; M Kirchgessner
Journal:  Arch Tierernahr       Date:  1973-05

6.  [Body mass development and hematological values of growing rats given varying amounts of Fe and Cu].

Authors:  J J Kim; E Grassmann; M Kirchgessner
Journal:  Zentralbl Veterinarmed A       Date:  1981

7.  Studies of the toxicity of copper to pigs. 1. Effects of oral supplements of zinc and iron salts on the development of copper toxicosis.

Authors:  N F Suttle; C F Mills
Journal:  Br J Nutr       Date:  1966       Impact factor: 3.718

8.  Variable effects of iron status on the concentration of ferritin in rat plasma, liver, and spleen.

Authors:  J E Hunter
Journal:  J Nutr       Date:  1978-03       Impact factor: 4.798

9.  [Fe and Cu content in the liver, spleen, kidney and heart of growing rats with variable Fe and Cu supply].

Authors:  E Grassmann; M Kirchgessner; J J Kim
Journal:  Z Ernahrungswiss       Date:  1983-06

10.  Iron metabolism in copper-deficient swine.

Authors:  G R Lee; S Nacht; J N Lukens; G E Cartwright
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.